Table 6 Global market forecast for vascular stents (2016–2020) [Unit: million USD] [11]
From: Analysis of trends and prospects regarding stents for human blood vessels
| Classification | Subclass | 2016 | 2017 | 2018 | 2019 | 2020 | CAGR(%) |
|---|---|---|---|---|---|---|---|
| Coronary Artery Stents | Bare Metal Stents | 508 | 490 | 472 | 456 | 445 | −3.3% |
| Bioresorbable Stents | 205 | 221 | 240 | 262 | 287 | 8.8% | |
| Covered Stents | 140 | 141 | 144 | 147 | 152 | 2.1% | |
| Drug Eluting Stents | 4658 | 4757 | 4891 | 5067 | 5282 | 3.2% | |
| Sum | 5371 | 5468 | 5604 | 5785 | 6014 | 2.9% | |
| Neurovascular Stents | Neurovascular Stents | 141 | 150 | 160 | 171 | 182 | 6.7% |
|
Peripheral Vascular Stents | Fem-pop Artery Stents | 498 | 533 | 577 | 617 | 659 | 7.3% |
| Iliac Artery Stents | 833 | 889 | 963 | 1026 | 1094 | 7.1% | |
| Infrapop Artery Stents | 176 | 188 | 204 | 217 | 225 | 6.3% | |
| Total | 1507 | 1611 | 1744 | 1861 | 1979 | 7.0% |